CIK 0001410098
- Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Grant or award Director acquired 17,500 shares (grant or award)
- 4 Exercise or conversion Exec VP of Tech Operations acquired 18,029 shares (option exercise)
- 4 Open-market buy Director bought 20,000 shares at $1.18 ($23,500)
- 4 Open-market buy Director bought 100,000 shares at $1.24 ($124,410)
- 4 Open-market buy Director bought 50,000 shares at $1.47 ($73,300)
- 4 Exercise or conversion EVP, Head of Clinical Ops. acquired 40,000 shares (option exercise)
- 4/A Grant or award Director acquired 22,000 shares (grant or award)
- 4/A Derivatives Options or other derivatives
- 4/A Grant or award Director acquired 10,000 shares (grant or award)
- 4/A Grant or award Director acquired 12,500 shares (grant or award)
- 4/A Grant or award Director acquired 10,000 shares (grant or award)
- 4/A Shares withheld for taxes Director gave up 468,750 shares (to pay taxes)
- 4/A Grant or award Director acquired 14,000 shares (grant or award)
- 4/A Grant or award Director acquired 16,000 shares (grant or award)
- 4 Open-market buy Exec VP of Tech Operations bought 250,000 shares at $1.45 ($363,150)
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at an average $1.22 ($30,495)
- 4 Open-market buy Chief Financial Officer bought 25,000 shares at $1.17 ($29,213)
- 4 Open-market buy Director bought 50,000 shares at $1.30 ($64,795)
- 4/A Grant or award Director acquired 10,000 shares (grant or award)
Page 12 of 26 · 515 filings